Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Acute Treatment-Induced Pulmonary Fibrosis
NCT01917877Phase 2Recruiting
- Sponsor
- Affiliated Qingdao Central Hospital of Qingdao University
- Start
- Aug 2013
- Primary completion
- Dec 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in pulmonary fibrosis (PF), sponsored by Affiliated Qingdao Central Hospital of Qingdao University. Started Aug 2013; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT01917877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01917877.